0001437749-26-015750
SEC filingUltralife reported a challenging Q1 FY2026, with revenue down 6.5% and operating income turning negative, reflecting operational disruptions and margin pressure — driven by lost production days, unfavorable sales mix, and one-time costs aimed at improving manufacturing efficiency.
The 6.5% year-over-year revenue decline to $47.4M reflects broader commercial sales weakness, which management attributes in part to lost production days resulting from the failure of the substation supplying power to the Newark, NY facility and winter blizzards. A prolonged shutdown to conduct a comprehensive physical inventory at the Raynham, MA facility further constrained output. These events contributed to reduced factory volume, compounding pressure on gross margin, which stood at 21.3% — down from prior-year levels — due to unfavorable sales mix and inefficiencies arising from disrupted operations.
Operating income declined to a loss of $215.0K, reversing the $3.4M gain in Q1 FY2025. This shift resulted from the combined effect of lower revenue, compressed gross profit, and higher operating expenses. Management notes that operating expenses increased year-over-year, reflecting both continued investment in new product development and certain one-time, non-recurring costs. The inclusion of these non-recurring items contributed meaningfully to the decline in operating income.
Net income fell to a loss of $451.0K, compared to income of $1.9M in Q1 FY2025, aligning with the deterioration in operating results. Diluted EPS was -$3.00, a significant change from $0.02 in the prior-year quarter, driven by the net loss and the weighted-average share count. The magnitude of the EPS change is amplified by the small base in the prior period, but the direction reflects the fundamental shift in profitability.